Handout for Biology of Mental Disorders (BCS 246)
Session 19 (11/19)
Today's Handout: Trimble C.8 (Schizophrenia pp. 183-225) with emphasis on DSM IV and Mesulam integration (can we make sense of this syndrome in terms of our previous knowledge?)
Introduction
Genetics
Major findings so far are the familial pattern, including MZ/DZ twin studies
Strong evidence of genetic factor, strong evidence for other factors in addition
Note: Study showing offspring of "unaffected" MZ twin have
just as high a risk as offspring of
the affected twin ("carrier" of risk genes or presence of epistasis?)
Limited evidence of syndromal heritability (i.e. paranoid vs. non-paranoid sub-type), actually
better evidence for paranoia vs. schizophrenia in this regard (now called delusional disorder)
"Schizophrenia spectrum" big these days: paranoid personality
disorder, schizotypal, schizoid
Caution: "positive" schizotypy does not seem specific to schizophrenia (also increased in
families of bipolar patients), whereas "negative"
schizotypy may be more specific
Gottesman at recent meeting indicates that there are now over six replications of strong linkage of
several genetic markers in MULTIPLE FAMILIES!!! This has to date never been shown and would be most exciting. This data is in abstract form only and will be published soon. Bad news is that none of the markers make a lot of sense in terms of current theories (linked to dopamine or serotonin receptors, enzymes for catechol metabolism (tyrosine
hydroxylase [TH], monoamine oxidase [MAO], etc.)
HLA A9 higher in paranoid schizophrenia, the pseudoautosomal area has not shown promise (Crow's theory)
Peripheral metabolic and biochemical findings and dopamine (DA) hypothesis
Transmethylation theory (methionine loading causes increased psychosis in some patients),
unclear whether methionine is causing increase in abnormal
substance or interfering with tryptophan uptake (acting as serotonin depleter)
MAO tends to be decreased in paranoid patients and those with a family history of psychosis
Dopamine (DA) hypothesis (supported entirely by indirect evidence), more appropriately the dopamine theory of antipsychotic efficacy
Many DA agonists cause psychosis (but this is usually after prolonged use)
Amphetamine can cause increase in psychotic symptoms in schizophrenic patients
Antipsychotics share ability to block DA receptors
Clinical potency of antipsychotics highly correlated with D2 DA receptor affinity (not D1 DA
receptors, noradrenergic, serotonergic, or histamine receptors
Note: the time course problem has been somewhat solved by Grace et al., who showed depolarization
block of DA cells occurring 3 weeks after initiation of antipsychotic meds
Limited evidence of DA metabolite abnormalities (HVA excess), this found mostly in positive
symptom patients and those with pos. family history
Plasma HVA positively associated with positive schizotypal sxs, and negatively with negative schizotypy
Fairly well replicated finding of increase in plasma HVA after initiation of antipsychotic, with
gradual decline over 2-3 weeks
Problems with hypothesis include:
Not all patients get worse with amphetamine (some improve!!)
No direct evidence of a dopamine excess, and some evidence of decreased DA in a subgroup
Excess receptors, increased sensitivity actually more consistent with DA reductions!
Brain tissue and CSF findings
Neurochemistry
High HVA in family history positive patients
Generally, no change in overall group means compared to controls, but relationships between
HVA and symptoms (low HVA -> greater DA sensitivity
and increased "first rank
symptoms" and thought disorder; low HVA linked to poorer prognosis)
Increased NE metabolite MHPG in paranoid patients
Most post-mortem studies show normal levels as group, but some found increased DA in basal
ganglia regions and septum (and relation to paranoid sub-group)
Increased DA in left amygdala found in two studies
Increased D2 binding, complicated by previous drug treatment, with some studies examining
non-medicated patients, including a study showing increased
D4 receptor density
Peptide levels in brain regions seem to be altered but unclear how medication affects this,
CCK most promising lead at this time (decreased in hippocampus, amygdala of negative sx patients)
Excitatory amino acid and GABA assays show evidence for decreased cortical excitatory
transmission in some areas of limbic cortex
Neuropathology
Generally positive findings (only 5/60 studies negative) but very inconsistent in their findings
Overall brain volume decreased by approximately 6-8 percent
Regions with specific abnormalities include thalamic (medial dorsal nucleus), hypothalamic,
periventricular, periaqueductal and basal forebrain areas
Entorhinal cortex and hippocampal cytoarchitectural abnormalities (abnormal cell positions,
apparent lack of "normal" migration, reduced cell
sizes etc.)
Decreased neuronal density of certain layers of frontal, cingulate, and motor cortex, with
evidence of excessive association cortex connections
Decreased small interneurons (inhibitory) of cingulate cortex
Electrophysiology
Clinical EEG findings (many studies showing abn. particularly in non-familial patients)
Very important, older findings in patients with depth electrodes inserted for epilepsy study:
Limbic abnormalities
Spiking in septal region (septum, olfactory tubercle, nucleus accumbens, diagonal band,
part of gyrus rectus), an area with extensive frontal/temporal
connections
Spiking occurred only when patients were actively psychotic
Violence and aggression related to amygdala and hippocampal discharges
Auditory thalamus activated during hallucinations (auditory likely)
Increased beta and slow activity with little alpha noted in patients and "high risk" subjects
"Ramp" activity in patients during psychotic behavior (monotonic
decrease in power from low
frequency to high frequency [no alpha peak])
similar to epilepsy patients at time of subcortical
discharge
Some studies, poorly replicated suggest left sided abnormalities related to positive psychotic symptoms
Plug for our findings: late waveforms all reduced with no relation to symptoms, while middle
latency waveforms not reduced as group (compared
to controls), but highly correlated with symptom subtype (in agreement with
DA modulation and excess DA -> reduced amplitude)
Radiological findings
Pneumoencephalography (30 studies, most showed increased ventricular size)
CT data (first study 1976) similar to neuropathologic findings, with almost all positive studies but
no "specific" finding
Lateral and 3rd ventricular enlargement, cortical widening (called atrophy by some but
very unlikely, most likely neurodevelopmental)
A number of studies find greater left than right abnormalities
Another plug for our data: lateral ventricular enlargement not specific, but 3rd ventricular
enlargement in over 1/3 of patients and none of controls
Low HVA noted in patients with large ventricles in some studies (as well as negative sxs)
Unclear as to whether a subgroup may have progressive changes (as a group, the abnormality seems
fairly stable over time)
See table 7 page 206 for MRI summary
Functional imaging and PET using receptor ligands
Hypofrontality earliest sign
Findings mixed from one sample to another
Hyperfrontality noted in acute patients, hypofrontality in medicated and chronic
Frontal activity decreases with chronicity and medication administration
Activated studies (i.e. cognitive task at time of ligand injection)
Inability to "light up" or activate frontal regions
One study showed nl pattern with continuous performance test, abn. with Wisconsin Card Sort
(seems to control for attention, motivation, but WCST
still much harder test!!)
Hallucinations related to increased activity in anterior cingulate, striatum,
and unimodal auditory cortices
D2 density findings totally controversial, with an initial study showing increased D2 receptors and all
subsequent studies failing to show this
Viral hypothesis
Again, controversial. No direct evidence of slow virus or typical viral cause
Pattern of increased winter births in schizophrenia
Viral illness in 2nd trimester of pregnancy may increase risk of schizophrenia
Other neurologic illnesses and psychosis
Temporal lobe epilepsy (TLE), Huntington's, narcolepsy, "midline"
cerebral pathology
Motor abnormalities in family members of SZ patients, and in "high risk" children
Smooth pursuit eye movements abn. in most? patients as well as many 1st degree relatives
Neuropsychological abnormalities
Numerous, with paranoid patients having least and disorganized having most
Medication improves impairment generally (decreased distraction by psychosis?)
Liddle again
Poverty of movement, speech, affect -> impaired abstract thinking and long term memory
Disorganization syndrome (thought disorder, etc.) -> impaired concentration, new learning
Reality distortion -> only impairment was in figure/ground perception
Notes for me:
- Slides of syndromal pies
- Slides of brain regions: Mesulam, MRI, anatomic cross sections
- Discuss Tony Grace's theory?
December 4, 1996